Skip to main content

3M™ Tegaderm™ CHG Chlorhexidine Gluconate Gel Pad, 1664, 1.94 in x 2.44in, 25/CAR, 4 CAR/CS, 100/CS

United States

Hover over image to zoom

3M™ Tegaderm™ CHG Chlorhexidine Gluconate Gel Pad, 1664, 1.94 in x 2.44in, 25/CAR, 4 CAR/CS, 100/CS

About the product

The 3M™ Tegaderm™ CHG Chlorhexidine Gluconate Gel Pad 1664 is an antimicrobial (CHG) gel pad designed to protect insertion sites and conform around a wide variety of percutaneous devices. This transparent CHG gel pad combines versatility with site visibility and antimicrobial protection.

  • Overall Width (Imperial) : 1.9300
  • Overall Length (Imperial) : 2.4400
  • Overall Length (Metric) : 6.2000
  • Overall Width (Metric) : 4.9000
  • Dressing Type : Film
  • Brand : Tegaderm™

Product Details

Engineered for versatility and antimicrobial protection.

Now you can provide your patients antimicrobial protection around a wide variety of percutaneous devices.

Engineered for versatility and antimicrobial protection.
Help to reduce risks across extraluminal access points

Help to reduce risks across extraluminal access points

Use the 3M™ Tegaderm™ CHG Chlorhexidine Gluconate Gel Pad 1664 pad for a variety of percutaneous devices, including implanted ports, large bore catheters, surgical drains and bone pins used in the care of oncology, hematology, orthopedic and plastic surgery patients..

3M™ Tegaderm™ CHG Gel Pad 1664 provides site visibility and immediate and continuous antimicrobial activity – reducing skin flora and preventing its regrowth – for up to 7 days without additional moisture required to activate. The highly breathable film atop the CHG gel pad helps to release moisture. The gel pad remains clear and protects even in the presence of blood, saline and exudates. The adhesive border provides gentle, yet strong adherence to skin, and the pre-cut slit in the gel pad is designed to conform around a variety of percutaneous devices.
To use 3M™ Tegaderm™ CHG Chlorhexidine Gluconate Gel Pad 1664 with intravascular devices, reference the below steps.
Prepare

Prepare

Prepare site according to facility protocol. Ensure site is completely dry. Remove liner 1, then liner 2 as shown above.

Press

Press

Place CHG gel pad around the device, covering the catheter insertion site and ensuring that the device rests upon the slit of the gel pad. Do not stretch during application. Apply firm pressure to enhance adhesion.

Secure

Secure

According to facility protocol, secure the catheter with the appropriate transparent, semi-permeable membrane dressing (e.g. 3M™ Tegaderm™ HP, 3M™ Tegaderm™ Diamond, 3M™ Tegaderm™ I.V. Port, 3M™ Tegaderm™ I.V. Advanced Securement).

Monitor

Monitor

Inspect the CHG gel pad daily and change as necessary, in accordance with facility protocol.

  • Standalone CHG gel pad engineered for versatility and antimicrobial protection
  • Tegaderm™ CHG is intended to reduce catheter-related bloodstream infections (CRBSIs) in patients with central venous or arterial catheters
  • CHG gel pad provides immediate and continuous antimicrobial activity – reducing skin flora and preventing its re-growth – for up to 7 days
  • Pre-cut slit conforms around drains, external fixator pins, implanted venous ports and a wide variety of other percutaneous devices (up to 40 FR)
  • Transparent CHG gel pad allows continuous site visibility to easily assess for early signs of infection
  • Adhesive border ensures gentle, yet strong adherence to skin
  • Absorbs low amount of exudate* *Bench testing shows that CHG gel can absorb 8x its weight in saline and 3x its weight in blood
  • Looking for port protection and securement for patients with implanted venous ports? View the 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Port Dressing, 1665

Product Specifications

Brand
Brand

Tegaderm™

Overall Length (Imperial)
Overall Length (Imperial)

2.4400

Overall Width (Metric)
Overall Width (Metric)

4.9000

Overall Length (Metric)
Overall Length (Metric)

6.2000

Dressing Type
Dressing Type

Film

Overall Width (Imperial)
Overall Width (Imperial)

1.9300

IV Site Management

Contact a Solventum representative

There was an error processing your request. Please try again later.